Showing results (51-60 of 1,311) with videos related to
Sort By:
Pageof 132
American Heart Journal|November 11, 2019
Income level and inequality as complement to geographical differences in cardiovascular trialsJoão Pedro Ferreira, Patrick Rossignol, Pooja Dewan, et al.European Journal of Heart Failure|January 10, 2018
Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database InitiativeJoão Pedro Ferreira, Kevin Duarte, Marc A Pfeffer, et al.European Journal of Heart Failure|November 10, 2021
Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCATJoão Pedro Ferreira, Jiankang Liu, Brian L Claggett, et al.JACC. Heart Failure|November 30, 2019
MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCATJoão Pedro Ferreira, Xavier Rossello, Romain Eschalier, et al.European Heart Journal|May 29, 2013
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trialBertram Pitt, Lars Kober, Piotr Ponikowski, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2017
Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.Hypertension (Dallas, Tex. : 1979)|October 16, 2013
Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudyVeronique Regnault, Jérémy Lagrange, Anne Pizard, et al.European Journal of Heart Failure|October 25, 2016
Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.The American Journal of Cardiology|April 11, 2018
Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative)Zied Frikha, João Pedro Ferreira, Erwan Bozec, et al.Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.Pageof 132